5 Stocks to Watch: Week of 9/22/2025

Hey. We’ve got an all-star list of tickers to watch this week, including:

• Analyst forecasts suggest Theravance Biopharma (TBPH) could nearly double in the coming year 
• Looking for a novel way to invest in semiconductors? Consider Cirrus Logic (CRUS) 
• Tapestry (TPR) has gained over 30% since we added it to the Zen Investor portfolio. Here’s why the move may not be over.
• Also back on the list: PagerDuty (PD). Keep reading to find out why. 
• Myr Group (MYRG) proves that power grid modernization = steady growth. 

P.S. Missed last week's picks? Get them here.

A note from our sponsors...

1- Theravance Biopharma (NASDAQ: TBPH) 

Theravance Biopharma focuses on developing and commercializing respiratory and inflammation therapies. The company maintains a lean business model that relies significantly on royalties and a streamlined pipeline. Wall Street is quite confident that the stock will soar — TBPH is currently trading at quite an attractive valuation and has a hefty checkbook to back it up.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $14.05 — get current quote > 

Max 1-year forecast: $28.00 

Why we’re watching:

• Analyst coverage of TBPH is unanimously bullish — at present, 3 equity researchers issue ratings for the stock, and all 3 of them have given it a Strong Buy rating. See the ratings  
• Moreover, the average 12-month price forecast for Theravance Biopharma shares is currently pegged at $25.67, which implies a hefty 79.49% upside. 
• Mayank Mamtani of B. Riley Securities (a top 4% rated analyst) recently initiated coverage on TBPH with a Strong Buy rating and a Street-high $28 price target.
• Mamtani called Theravance Biopharma a fully integrated biopharma company with a track record of discovering, developing, and commercializing respiratory therapies.
• Now that the company has monetized its non-core asset Trelegy, it is well positioned to benefit from a recent strategic review process aimed at unlocking shareholder value, the analyst told readers.
• Our rating system, Zen Ratings, takes into account 115 factors when evaluating stocks. Equities that rank in the top 5%, like Theravance Biopharma, have a Zen Rating of A and have provided an average annual return of 32.52% since the early 2000s. TBPH actually ranks in the top 1% — it is rated 18th overall out of the 4,600 stocks that we keep track of.
• Each Zen Rating is a composite score of 7 Component Grade ratings. For example, TBPH ranks in the 92nd percentile in terms of Value.
• Growth and Financials are Theravance Biopharma’s strongest suits, however — in these categories, the stock ranks in the top 4% and 3% of equities, respectively. (See all 7 Zen Component Grades here >)

2- Cirrus Logic (NASDAQ: CRUS) 

Our next pick designs the high-performance mixed-signal chips that power things like sound quality, voice recognition, and power management in smartphones, earbuds, and laptops. While it might not attract any headlines, Cirrus Logic offers a unique way to invest in an essential corner of the semiconductor market.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $122.13 — get current quote > 

Max 1-year forecast: $130.00 

Why we’re watching:

• CRUS shares are tracked by 3 Wall Street analysts, whose coverage is split between 2 Strong Buy ratings and 1 Hold rating. See the ratings
• Stifel Nicolaus equity researcher Tore Svanberg (a top 1% rated analyst) recently maintained a Strong Buy rating on the stock and increased his price target from $120 to a Street-high $130. 
• Svanberg said Cirrus Logic is "ideally-placed to benefit" from the new trend of speech as a key Human-Machine/AI Interface on laptops, noting that it already sells to the top five laptop PC OEMs and is featured in laptops made by its biggest customer.
• Cirrus Logic ranks in the 91st percentile of the stocks that we track, giving it a Zen Rating of B, which has historically corresponded to an average annual return of 19.88%.
• CRUS is currently trading at a very modest price-to-earnings (P/E) ratio of 17.62x — so it’s no wonder that it ranks in the top 4% when it comes to Value.
• In addition, the company’s strong balance sheet, exemplified by a debt-to-equity ratio of just 0.19, means that it ranks in the top 1% in terms of Financials. (See all 7 Zen Component Grades here >)

3- Tapestry (NASDAQ: TPR) 

Tapestry (TPR), a suite of luxury retail brands, has gained over 30% since we added it to the Zen Investor portfolio. But the move may not be over. It delivered a strong double beat in its last quarterly report; when you factor in a robust direct-to-consumer model, strong growth in online sales, and ambitious forecasts, it’s clear why Tapestry deserves a closer look.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $112.43 — get current quote > 

Max 1-year forecast: $142.00 

Why we’re watching:

• TPR shares have 7 Strong Buy ratings, 3 Buy ratings, and 2 Hold ratings. See the ratings 
• In addition, the max forecast for Tapestry suggests nearly 30% potential upside.
• JP Morgan researcher Matthew Boss (a top 10% rated analyst) maintained a Strong Buy rating on the stock following Tapestry's 2025 Investor Day event on 2025/09/10. and increased his price target from $139 to a Street-high $142.  
• According to the analyst, the company's three-year strategy is really "the floor" from which there is room to grow.
• Tapestry is currently the 3rd highest rated stock in the Luxury industry, which has an Industry Rating of B.
• TPR ranks in the top 10% of the stocks that we track, giving it a Zen Rating of B.
• In terms of both Growth and Safety, Tapestry shares rank in the 85th percentile of equities.
• However, like in the case of our previous entries, Financials are TPR’s biggest strength — as the stock ranks in the top 3% in this category. (See all 7 Zen Component Grades here >)

4- Myr Group (NASDAQ: MYRG)

Myr Group is a specialty contractors that build and maintains electrical infrastructure across the U.S. and Canada. Its main focuses are high-voltage power lines, substations, and electrical work for large-scale industrial projects. With electrification showing no signs of stopping — coupled with constant calls for grid modernization, MYRG is set to benefit from steady demand. 

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $184.28 — get current quote > 

Max 1-year forecast: $211.00 

Why we’re watching:

• Myr Group shares are a consensus Buy per Wall Street analysts. The stock currently has 3 Strong Buy ratings, 1 Buy rating, and 3 Hold ratings. See the ratings  
• The average 12-month price forecast for the stock currently sits at $192.86, and implies a 9.68% upside.
• KeyBanc researcher Sangita Jain (a top 8% rated analyst) maintained a Strong Buy rating on MYRG after the company’s Q2 2025 earnings call, and increased her price target from $205 to a Street-high $211. 
• Jain said the "strong" results were highlighted by consensus-beating EPS.
• The quarter generated previously indicated mid-to-high-single-digit core revenue growth in both segments in 2H 2025, the analyst continued, with decent project bookings momentum in both segments.
• The stock price has responded favorably to improved execution and a lower-risk MSA-driven project profile, Jain said, looking ahead.
• Myr Group is the 2nd highest-rated stock in the Engineering & Construction industry, which has an Industry Rating of A.
• MYRG currently ranks in the top 1% of the equities that we track. To be more precise, it is rated 32nd overall out of roughly 4,600 stocks — giving it a Zen Rating of A.
• Myr Group shares rank in the 77th percentile in terms of three Component Grade ratings — Value, Sentiment, and Financials. 
• When it comes to Artificial Intelligence, MYRG ranks in the 78th percentile of stocks.
• The stock has surged by 47.07% in the past six months — so it’s no wonder that it ranks in the top 17% with regard to Momentum.
• However, Growth is the star of the show here — as MYRG ranks in the top 1% of equities in this category. (See all 7 Zen Component Grades here >)

A note from our sponsors...

5- PagerDuty (NYSE: PD) 

In case you missed our recent feature on PD as a potential dip buy, here’s the story. Despite a challenging set of circumstances, growth expectations are quite high, and the company has the balance sheet to finance high-margin opportunities.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $16.31 — get current quote > 

Max 1-year forecast:  

Why we’re watching:

• True: Analyst ratings are mixed. The stock currently has 2 Strong Buy ratings, 1 Buy rating, 3 Hold ratings, and 1 Sell rating. See the ratings  
• That said, the average 12-month price forecast for PD shares, currently set at $18.43, paints a much more bullish picture, as it implies a 12.1% upside.  
• Canaccord Genuity researcher Kingsley Crane (a top 19% rated analyst) maintained a Strong Buy rating on the stock after the company reported its Q2 2026 earnings. Crane also decreased his price target from $21 to $19.
• Crane pointed to the quarter's "mixed" results, headlined by revenue just below the midpoint of guidance.
• The print reflected PagerDuty's ongoing GTM realignment against broad-based seat-based headwinds primarily among SMBs, but more recently among enterprise customers as well.
• That said, the announcement that Todd McNabb will step in as CRO should be well-received by investors, Crane predicted.
• PagerDuty is the 4th highest-rated stock in the App industry, which has an Industry Rating of B.
• PD currently ranks in the 97th percentile of the stocks that we track, giving it a Zen Rating of A, which has historically corresponded to an average annual return of 32.52%.
• Financials and Growth are PagerDuty’s biggest advantages — in these categories, the stock ranks in the top 10% and top 3% of stocks, respectively. (See all 7 Zen Component Grades here >)

BONUS: 1 Stock to Sell: Westlake Corp (NYSE: WLK)

Bonus! This isn’t your run of the mill recommendation. For reasons we’ll get into, you shouldn’t buy WLK shares — you might, however, want to sell them if you own then, or perhaps even short them.

Zen Rating: F (Strong Sell) — see full analysis >  

Recent Price: $89.04 — get current quote > 

Max 1-year forecast:  

Why we’re watching:

• Westlake Corp shares have 5 Strong Buy ratings, 2 Buy ratings, and 7 Hold ratings. See the ratings
• JP Morgan researcher Jeffrey Zekauskas (a top 16% rated analyst) recently maintained a Hold rating on WLK, and slashed his price target from $75 to $73. Zekauskas’ revised price target implies a hefty 16.76% downside.
• To put it bluntly, WLK is a straggler in a troubled industry — the stock is currently rated 52nd (out of a total of 53) in the Speciality Chemical industry, which has an Industry Rating of C.
• Westlake Corp is one of the 7 stocks in our exclusive Zen Strategies Stocks to Short portfolio. The portfolio consists of equities that have weak fundamentals — so it’s a great place to start when looking for short selling opportunities.
• WLK ranks in the bottom 1% of the stocks that we track. In fact, it is currently rated 4530th out of 4,557.
• Westlake Corp shares rank in the bottom 1% of equities in terms of both Value and Sentiment.
• With regard to Growth, WLK ranks in the bottom 3%. When it comes to Momentum, the stock ranks in the bottom 12%. Lastly, it ranks in the bottom 25% according to Financials. (See all 7 Zen Component Grades here >)

What to Do Next?

• 77 Best Stocks NOW! >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.